Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 17,170 | 28,850 | 43,747 | 26,484 | 46,527 |
| Cost of Goods | 13,009 | 21,968 | 29,302 | 17,463 | 28,304 |
| Gross Profit | 4,161 | 6,882 | 14,445 | 9,021 | 18,223 |
| Operating Expenses | 11,569 | 14,109 | 19,328 | 13,626 | 12,998 |
| Operating Income | -7,399 | -6,259 | -4,581 | -4,142 | 5,529 |
| Interest Expense | 310 | 235 | 555 | 422 | 412 |
| Other Income | -24 | -248 | -6 | -265 | -694 |
| Pre-tax Income | -7,733 | -6,742 | -5,142 | -4,829 | 4,423 |
| Income Tax | 603 | 33 | 457 | 295 | 86 |
| Net Income Continuous | -8,336 | -6,775 | -5,599 | -5,124 | 4,337 |
| Net Income | $-8,336 | $-6,775 | $-5,599 | $-5,124 | $4,337 |
| EPS Basic Total Ops | -773.38 | -593.53 | -557.55 | -575.54 | 16,402.88 |
| EPS Basic Continuous Ops | -759.30 | -598.61 | -555.75 | -583.87 | 5,990.74 |
| EPS Diluted Total Ops | -773.38 | -593.53 | -557.55 | -575.54 | 16,402.88 |
| EPS Diluted Continuous Ops | -759.30 | -598.61 | -555.75 | -583.87 | 5,990.74 |
| EBITDA(a) | $-6,543 | $-5,388 | $-3,675 | $-3,250 | $6,040 |